See more : Fortinet, Inc. (FTNT) Income Statement Analysis – Financial Results
Complete financial analysis of Doximity, Inc. (DOCS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Doximity, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Kimberly-Clark Corporation (0JQZ.L) Income Statement Analysis – Financial Results
- Schrole Group Ltd (SCL.AX) Income Statement Analysis – Financial Results
- Rana Gruber ASA (RANA.OL) Income Statement Analysis – Financial Results
- Nippon Aqua Co., Ltd. (1429.T) Income Statement Analysis – Financial Results
- China Bozza Development Holdings Limited (1069.HK) Income Statement Analysis – Financial Results
Doximity, Inc. (DOCS)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.doximity.com
About Doximity, Inc.
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 475.42M | 419.05M | 343.55M | 206.90M | 116.39M | 85.70M |
| Cost of Revenue | 50.67M | 53.49M | 39.79M | 31.20M | 14.90M | 10.89M |
| Gross Profit | 424.75M | 365.56M | 303.76M | 175.70M | 101.49M | 74.81M |
| Gross Profit Ratio | 89.34% | 87.24% | 88.42% | 84.92% | 87.20% | 87.29% |
| Research & Development | 81.98M | 80.19M | 62.35M | 43.87M | 32.44M | 27.50M |
| General & Administrative | 37.83M | 36.75M | 35.75M | 16.49M | 7.44M | 7.34M |
| Selling & Marketing | 133.13M | 123.52M | 92.13M | 62.03M | 39.45M | 33.05M |
| SG&A | 170.96M | 160.27M | 127.88M | 78.53M | 46.89M | 40.39M |
| Other Expenses | 0.00 | 8.05M | 469.00K | 4.17M | 1.35M | -59.00K |
| Operating Expenses | 260.88M | 240.45M | 190.23M | 122.40M | 79.33M | 67.89M |
| Cost & Expenses | 311.54M | 293.94M | 230.01M | 153.59M | 94.23M | 78.77M |
| Interest Income | 21.66M | 9.29M | 2.15M | 301.00K | 1.46M | 1.07M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 10.27M | 12.31M | 6.20M | 6.14M | 2.90M | 551.00K |
| EBITDA | 182.08M | 125.11M | 113.54M | 63.90M | 26.41M | 7.47M |
| EBITDA Ratio | 38.30% | 32.31% | 34.52% | 27.55% | 19.82% | 8.72% |
| Operating Income | 163.88M | 125.11M | 113.54M | 53.30M | 22.16M | 6.92M |
| Operating Income Ratio | 34.47% | 29.86% | 33.05% | 25.76% | 19.04% | 8.08% |
| Total Other Income/Expenses | 21.32M | 8.05M | 469.00K | 4.47M | 1.35M | 1.01M |
| Income Before Tax | 185.20M | 133.16M | 114.01M | 57.77M | 23.51M | 7.93M |
| Income Before Tax Ratio | 38.96% | 31.78% | 33.18% | 27.92% | 20.20% | 9.25% |
| Income Tax Expense | 37.62M | 20.34M | -40.78M | 7.56M | -6.22M | 98.00K |
| Net Income | 147.58M | 112.82M | 154.78M | 50.21M | 29.74M | 7.83M |
| Net Income Ratio | 31.04% | 26.92% | 45.05% | 24.27% | 25.55% | 9.14% |
| EPS | 0.78 | 0.58 | 0.81 | 0.12 | 0.06 | 0.05 |
| EPS Diluted | 0.72 | 0.53 | 0.70 | 0.12 | 0.06 | 0.05 |
| Weighted Avg Shares Out | 190.17M | 193.18M | 163.65M | 181.70M | 181.70M | 171.42M |
| Weighted Avg Shares Out (Dil) | 205.73M | 213.43M | 191.21M | 181.70M | 181.70M | 171.42M |
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity
NEW YORK , June 6, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS) and reminds investors of the June 17, 2024 deadline...
Doximity, Inc. Investors: June 17, 2024 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
SAN FRANCISCO, CA / ACCESSWIRE / June 6, 2024 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Doximity, Inc. ("Doximity" or the "Company") (NYSE:DOCS) who suffered losses from purchasing or otherwise acquiring Doximity common...
IMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or "the Company") (NYSE:DOCS) and certain...
DOXIMITY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS
NEW ORLEANS, June 05, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS), if...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. – DOCS
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW),...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Doximity, Inc. (DOCS)
LOS ANGELES, June 05, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 17, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or...
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) and reminds investors of the June 17, 2024 deadline...
IMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / June 5, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or "the Company") (NYSE: DOCS) and...
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS)...
DOXIMITY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS
NEW ORLEANS, June 04, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 17, 2024 to file lead plaintiff applications...
Source: https://incomestatements.info
Category: Stock Reports